IRCT20200716048118N1 IRCT 2020-11-25 Yas Daru The effect of Ganoderm on glycemic control in diabetic patients none Evaluation of the effect of Ganoderm lucidum (with usual diabetes medications) on blood glucose control in type 2 diabetic patients: A placebo-controlled double-blind clinical trial 2020-10-22 anticipated 72 Complete https://irct.ir/trial/51356 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple randomization by using random number table is used for randomization, Blinding description: physician is blind about the study group. Patient is blind about the study group. investigator is blind about the study group. data analyzer is blind about the study group. Assignment of patients in treatment and placebo groups is performed by a nurse out of above mentioned groups. 3 Diabetes mellitus type 2. Intervention 1: Intervention group: In this group patients take their oral diabetes medications without any changes and in addition, they receive treatment with ganoderma including one ganoderma capsule (one gram ganoderma) in morning and one in night for 12 weeks. Intervention 2: Control group: Placebo. In this group patients take their oral diabetes medications without any changes and in addition they receive treatment with placebo including one placebo capsule (one gram placebo) in morning and one in night for 12 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Due to security reason for patient data and pharmaceutic company